drugset / Trial / NCT00887276
Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to prove the clinical and bacteriological non-inferiority of ampicillin/amoxicillin versus moxifloxacin in hospitalized patients with non-severe community-acquired pneumonia.
Timeline
- Start
- 2008-11
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 0.5 g | Oral |
| Comparator | Ampicillin | Unknown | 2 g | Intravenous |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Intravenous |
Indications
No indication recorded.